首页 | 本学科首页   官方微博 | 高级检索  
     

黄芪甲甙对大鼠肾缺血再灌注损伤的远期防护作用
引用本文:Yu QC,Zhu TY,Zhang YK. 黄芪甲甙对大鼠肾缺血再灌注损伤的远期防护作用[J]. 中华医学杂志, 2004, 84(17): 1412-1415
作者姓名:Yu QC  Zhu TY  Zhang YK
作者单位:200032,上海,复旦大学中山医院泌尿外科
摘    要:目的 观察黄芪甲甙对大鼠肾缺血再灌注损伤 (IRI)远期改变的作用。方法 采用Sprague Dawley大鼠右侧肾切除 ,左侧肾动脉夹闭 6 0min肾IRI模型。实验动物分为肾IRI组 ,实验组 (astragalosideIV ,Astr)和假手术组 (Sham) ,观察肾IRI大鼠术后 4、12和 2 4周血清肌酐、尿蛋白 ,肾组织的病理 ,胶原染色及转化生长因子 (TGF) β1的变化。 结果 IRI组尿总蛋白随时间延长进行性增加 ,皮髓质交界处胶原染色增强且在术后 2 4周肾间质中胶原增加 ,同时术后 12周和 2 4周TGF β1的蛋白质和mRNA表达明显增加。Astr组上述改变虽然多于Sham组 ,但在 2 4周时明显低于IRI组 (P <0 0 5 )。结论 大鼠肾IRI 2 4周肾纤维化趋势明显增加 ,黄芪甲甙通过下调TGF β1的表达在一定程度上可以减轻肾脏损害。

关 键 词:黄芪甙  转化生长因子β  再灌注损伤
修稿时间:2004-01-30

Effect of astrgaloside IV on the long-term consequences of renal ischemia-reperfusion injury in rat
Yu Qin-Chao,Zhu Tong-Yu,Zhang Yong-Kang. Effect of astrgaloside IV on the long-term consequences of renal ischemia-reperfusion injury in rat[J]. Zhonghua yi xue za zhi, 2004, 84(17): 1412-1415
Authors:Yu Qin-Chao  Zhu Tong-Yu  Zhang Yong-Kang
Affiliation:Department of Urology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Abstract:OBJECTIVE: To observe the effect of astrgaloside IV (Astr) on the long-term consequences of renal ischemia-reperfusion injury (IRI) in rat. METHODS: Fifty-four male Sprague-Dawley rats were randomized into 3 equal groups: IRI group, Astr group, and sham operation group. All rats underwent right nephrectomy and isolation of the left renal artery. The left renal arteries of the IRI group and Astr group were gripped by vascular clamp for 60 minutes and that of the sham operation group was only isolated without gripping. Two milliliters of Astr solution (0.1 g/L) was perfused into the stomach of the rats in the Astr group three days before and after the operation respectively. The rats in the IRI and sham operation groups were perfused with normal saline of the same volume. Four, twelve, and twenty-four weeks after the operation 24-hour urine specimens of the rats were collected to detect the urine protein. At each time point 6 rats from each group were anesthetized and blood was collected from the abdominal aorta to measure the level of serum creatinine (Cr), their left kidneys were taken out to undergo pathological examination and extraction of mRNA. Histochemistry was used to detect the expression of tumor growth factor (TGF)-beta1 protein in the renal tissues. RT-PCR was used to detect the expression of TGF-beta1 mRNA. Collagen staining and immunohistochemistry were used to measure the proportion of collagen positive material to the total area. RESULTS: The level of urine protein was increased progressively, those 12 and 24 weeks after the operation in the IRI group were significantly higher than those in the Astr and sham operation groups (all P < 0.05). The serum Cr 4 weeks after the operation was 36 micromol/L +/- 4 micromol/L, significantly higher than those in the Astr and sham operation groups (31 micromol/L +/- 8 micromol/L and 31 micromol/L +/- 5 micromol/L), and the serum Cr levels 4 weeks 12 and 24 weeks after the operation in the IRI group remained significantly higher than those in the Astr and sham operation groups (all P < 0.05). Collagen staining showed that the glomerular basement membrane, tunica adventitia vasorum, and adventitia of renal tubule were remarkably redder in the IRI than in the Astr and sham operation groups. The expression of TGF-beta1 protein was progressively increased since 12 weeks after the operation in the IRI group, significantly stronger in the Astr and sham operation groups. The expression of TGF-beta1 mRNA was progressively increased since 12 weeks after the operation in the IRI and Astr groups, significantly stronger than that in the sham operation group (P < 0.05). However, the expression of TGF-beta1 mRNA 24 weeks after the operation was significantly stronger in the IRI group than in the Astr group (P < 0.05). CONCLUSION: After renal IRI the probability of development of renal fibrosis increases. Astrgaloside IV markedly ameliorates renal injury by downregulating the TGF-beta1 expression.
Keywords:Astrgal IN  Transforming growth factor beta  Reperfusion injury
本文献已被 CNKI 万方数据 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号